Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with healthcare practitioners and regulators.
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in Vadodara, formulation facility likely to get inspected.